NCT04725175View on ClinicalTrials.gov

Phase I Study Evaluating Safety and Tolerability of Escalating Single and Multiple Doses of of PIPE-307 and Food Effect in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

February 26, 2021

Primary Completion Date

September 1, 2021

Study Completion Date

September 1, 2021

Conditions
Multiple Sclerosis
Interventions
DRUG

PIPE-307

Single and multiple ascending oral doses of PIPE-307 tablets

DRUG

Placebo oral tablet

Single and multiple ascending oral doses of matching Placebo tablets

Trial Locations (1)

6009

Linear Clinical Research, Nedlands

Sponsors
All Listed Sponsors
lead

Contineum Therapeutics

INDUSTRY

NCT04725175 - Phase I Study Evaluating Safety and Tolerability of Escalating Single and Multiple Doses of of PIPE-307 and Food Effect in Healthy Volunteers | Biotech Hunter | Biotech Hunter